BARRECA, Massimo
BARRECA, Massimo
Dipartimento di Scienze Mediche e Chirurgiche
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells
2020-01-01 Barreca, M.; Spano, V.; Raimondi, M. V.; Montalbano, A.; Bai, R.; Gaudio, E.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P.
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches
2023-01-01 Bivacqua, R.; Romeo, I.; Barreca, M.; Barraja, P.; Alcaro, S.; Montalbano, A.
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors
2021-01-01 Spano, V.; Barreca, M.; Rocca, R.; Bortolozzi, R.; Bai, R.; Carbone, A.; Raimondi, M. V.; Piccionello, A. P.; Montalbano, A.; Alcaro, S.; Hamel, E.; Viola, G.; Barraja, P.
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types
2020-01-01 Spano, V.; Rocca, R.; Barreca, M.; Giallombardo, D.; Montalbano, A.; Carbone, A.; Raimondi, M. V.; Gaudio, E.; Bortolozzi, R.; Bai, R.; Tassone, P.; Alcaro, S.; Hamel, E.; Viola, G.; Bertoni, F.; Barraja, P.
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations
2022-01-01 Cilibrasi, V.; Spano, V.; Bortolozzi, R.; Barreca, M.; Raimondi, M. V.; Rocca, R.; Maruca, A.; Montalbano, A.; Alcaro, S.; Ronca, R.; Viola, G.; Barraja, P.
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma
2022-01-01 Grillone, K.; Riillo, C.; Rocca, R.; Ascrizzi, S.; Spano, V.; Scionti, F.; Polera, N.; Maruca, A.; Barreca, M.; Juli, G.; Arbitrio, M.; Di Martino, M. T.; Caracciolo, D.; Tagliaferri, P.; Alcaro, S.; Montalbano, A.; Barraja, P.; Tassone, P.
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma
2022-01-01 Barreca, M.; Spanò, V.; Rocca, R.; Bivacqua, R.; Maruca, A.; Montalbano, A.; Raimondi, M. V.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Rinaldi, A.; Bai, R.; Prota, A.; Abel, A. C.; Steinmetz, M.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells | 1-gen-2020 | Barreca, M.; Spano, V.; Raimondi, M. V.; Montalbano, A.; Bai, R.; Gaudio, E.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P. | |
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches | 1-gen-2023 | Bivacqua, R.; Romeo, I.; Barreca, M.; Barraja, P.; Alcaro, S.; Montalbano, A. | |
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors | 1-gen-2021 | Spano, V.; Barreca, M.; Rocca, R.; Bortolozzi, R.; Bai, R.; Carbone, A.; Raimondi, M. V.; Piccionello, A. P.; Montalbano, A.; Alcaro, S.; Hamel, E.; Viola, G.; Barraja, P. | |
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types | 1-gen-2020 | Spano, V.; Rocca, R.; Barreca, M.; Giallombardo, D.; Montalbano, A.; Carbone, A.; Raimondi, M. V.; Gaudio, E.; Bortolozzi, R.; Bai, R.; Tassone, P.; Alcaro, S.; Hamel, E.; Viola, G.; Bertoni, F.; Barraja, P. | |
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations | 1-gen-2022 | Cilibrasi, V.; Spano, V.; Bortolozzi, R.; Barreca, M.; Raimondi, M. V.; Rocca, R.; Maruca, A.; Montalbano, A.; Alcaro, S.; Ronca, R.; Viola, G.; Barraja, P. | |
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma | 1-gen-2022 | Grillone, K.; Riillo, C.; Rocca, R.; Ascrizzi, S.; Spano, V.; Scionti, F.; Polera, N.; Maruca, A.; Barreca, M.; Juli, G.; Arbitrio, M.; Di Martino, M. T.; Caracciolo, D.; Tagliaferri, P.; Alcaro, S.; Montalbano, A.; Barraja, P.; Tassone, P. | |
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma | 1-gen-2022 | Barreca, M.; Spanò, V.; Rocca, R.; Bivacqua, R.; Maruca, A.; Montalbano, A.; Raimondi, M. V.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Rinaldi, A.; Bai, R.; Prota, A.; Abel, A. C.; Steinmetz, M.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P. |